Cemat A/S
Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K
Copenhagen, 22 March 2021
ANNOUNCEMENT no 8/2021
Closely related persons transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 22 March 2021.
| Name: | Peter Taero Nielsen |
| Reason for filing: | Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the company |
| Company name: | Cemat A/S |
| Identification code and name: | ISIN DK0010271584 |
| Transaction type: | Purchase |
| Date: | 18 March 2021 |
| Market: | Nasdaq Copenhagen |
| Number of traded shares: | 45,764 |
| Price: | 0.48 |
Cemat A/S
Jaroslaw Pawel Lipinski
CEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
AAVantgarde8.1.2026 13:00:00 CET | Press release
AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference
Brunswick Exploration8.1.2026 13:00:00 CET | Press release
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
Nykredit Realkredit A/S8.1.2026 13:00:00 CET | Press release
Fixing of coupon rates – Nykredit Realkredit A/S
AccuStem Sciences, Inc.8.1.2026 13:00:00 CET | Press release
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
BitMEX8.1.2026 13:00:00 CET | Press release
BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
